morazzoni b
TRANSCRIPT
Polifenoli del vino e prevenzione di patologie cronico-degenerative
P. Morazzoni, W. Cabri Indena R&D
Corporate Twitter: @IndenaSpA
New England Journal of Medicine 366, 2333 (2012)
TOP 10 CAUSES OF DEATH (1900 vs 2010)
The role of diet, even at epigenetic level, in contributing to
modulate chronic-degenerative pathologies has been
established in a number of epidemiological studies.
In this contest, the role of secondary (and even primary)
metabolites contained in edible plants seems to be pivotal
in human homeostasis and in the modulation of the risk of
pathological conditions including cardiovascular diseases
and cancer.
ROLE OF DIET AND EDIBLE PLANTS
Epigenetic regulations consist of potentially reversible
changes in DNA methylation, histone modifications,
alteration in microRNA (miRNA) expression, without any
change in DNA sequence.
Several phytonutrients are demonstrated to modulate these
epigenetic regulators inducing heritable changes in gene
expression (i.e. those codifying for pivotal inflammation-
regulating factors, such as NF-kB …..).
S. Reuter et al., Genes Nutr. 6, 93 (2011)
EPIGENETIC REGULATIONS AND ROLE OF
DIETARY PHYTONUTRIENTS
R&D Indena focus is to identify phytonutrients provided
with a solid scientific background and to develop these
ingredients by optimizing their biological benefits for
improving quality of life.
INDENA MISSION IN CONSUMER HEALTH
IS THERE A REASONABLE BASIS
IN ORDER TO INTEGRATE PHYTONUTRIENTS
(AS SUPPLEMENTS OR FUNCTIONALIZED FOOD)
IN THE MODERN DIET?
EDIBLE PLANTS ARE TODAY USUALLY CHARACTERIZED BY A LOWER CONTENT OF PHYTONUTRIENTS
Agricultural selection has reduced the contents of phytochemicals in edible plants which have been selected for factors like appearance, succulence and yields (by means of pesticides).
INTENSIVE AGRICULTURE IS A WORLDWIDE NEED
Productivity
Hectares dedicated to agriculture
Journal of the American College of Nutrition 2004, 23, 669
25% less proteins
MODERN DIET IS MARKEDLY REDUCED IN DIVERSITY
•Only 1% of the total 300,000 higher plants has been historically utilized for food. Roughly 150 species are commercially cultivated.
•Caloric intake is derived mostly from 4 plant species (wheat, rice, soy, corn). These plants represent the basis upon which the world’s population is fed.
The concept of
optimized nutrition
arises from the
convergence of
information from
basic biomedical
science with
epidemiological data.
HIGH QUALITY INGREDIENTS
FULFILLING OF HEALTH CLAIM CRITERIA
COMPATIBILITY WITH FOOD PREPARATION PROCESSES
THE PROCESS OF
OPTIMIZING NUTRITION
CAN BE ENVISAGED ALSO AS A
CONSTANT SUPPLY OF SELECTED PHYTONUTRIENTS
(MOSTLY FROM EDIBLE PLANTS)
CHARACTERIZED BY WELL ESTABLISHED BIOLOGICAL PROPERTIES
DIETARY SUPPLEMENTS FUNCTIONALIZED FOOD
INDENA STRATEGIC APPROACHES FOR THE DEVELOPMENT OF EDIBLE PLANT-DERIVED PRODUCTS
•Rediscovery of plants from Eastern and Western area
Grape, artichoke, lupin….
•Targeted combinations
Combination for appetite control, cholesterol lowering formulation….
•Optimization of extract “characteristics” (bioavailability, standardization, new formulation)
Phaseolus vulgaris, curcumin….
INDENA MAJOR AREA IN HEALTH NUTRITION
CARDIOVASCULAR HEALTH
Metabolic disorders
GASTROENTEROLOGY
Functional dyspepsia
IBS/IBD
MENTAL HEALTH
Cognitive decline
EXAMPLES OF INDENA EDIBLE PLANTS DERIVED STANDARDIZED EXTRACTS
LEUCOSELECT® Vitis vinifera L.
OLEASELECT®
Olea europaea L.
GREENSELECT® Camellia sinensis (L.) O. Kuntze
MIRTOSELECT® Vaccinium myrtillus L.
MADEGLUCYL® Syzygium cumini (L.) Skeels
BEANBLOCK®
Phaseolus vulgaris L.
PYCRINIL®
Cynara cardunculus L. subsp. Scolymus
PRO-GAMMA™ Lupinus albus L.
MERIVA® Curcuma longa L.
SOYSELECT®
Glycine max L.
ENOVITA® Vitis vinifera L.
orientalis
(from Jordan valley)
occidentalis
(from Nile valley and Western Europe)
pontica
(intermediate area)
sylvestris (Gmelin) Hegi
(South-West Asia, South-Central Europe)
sativa Hegi
(Many of these cultivated species are derived from the sylvestris subspecies)
Vitis vinifera L. (Vitaceae family)
Caspian Sea region (Asia minor)
EAST Turkey, Persia, India, China
(128 B.C.)
WEST North Africa, Egypt
(23th c. B.C.)
Greece (18th-16th c. B.C.)
Italy (9th-7th c. B.C.)
Gaul (6th c. B.C.)
Vitis vinifera L. CULTIVATIONS: THE HISTORICAL TRACK – OLD PERIOD
Mexico
USA
South America
(East Coast FAILED)
(West Coast SUCCESS)
Vitis vinifera L. CULTIVATIONS: THE HISTORICAL TRACK – NEW WORLD
South Africa
(16th c. A.D.)
Australia
New Zealand
Egypt (23th c. B.C.)
Wall paintings from the Kha'emwese's tomb of ancient Thebae: various steps of grape harvest.
Vitis vinifera L. CULTIVATIONS: THE HISTORICAL TRACK
Vitis vinifera L. THROUGH THE CENTURIES
Fruits and leaves (and their derivatives) have been utilized for
both edible and medicinal purposes by basically most of the
populations involved in the cultivation of grapevine.
Ancient Egyptians, the Hippocratics (5th-4th c. B.C.),
Theofrastus (4th c. B.C.), Dioscorides, Pliny (1st c. A.D.), Galen
(2nd c. A.D.) described the medicinal properties of grapes.
FRUITS
LEAVES
MAIN MEDICINAL PROPERTIES AND THERAPEUTICAL USES OF Vitis vinifera L. DERIVATIVES
Vitis vinifera L. SEEDS ARE THE PART OF THE PLANT WITH THE HIGHEST CONCENTRATION OF POLYPHENOLS
OLIGOMERIC PROANTHOCYANIDINS: ONE OF THE MOST CHARACTERIZING GROUPS OF POLYPHENOLS IN Vitis vinifera L.
Sharmila Shankar, Brahma N. Singh, and Rakesh K. Srivastava, in: Nutrition, Diet and Cancer, Chapter 10, Plant Polyphenols and Their Role in Cancer Prevention and Chemotherapy, p 209, S. Shankar and R.K. Srivastava (Eds.), Springer, 2012
Modified from:
OPC: THE PHARMACEUTICAL APPROACH…
The pharmaceutical utilization of OPC
(starting from the 1980s) has been mostly concerned
with a proprietary product (Endotelon) which contains
as active principle a highly standardized extract from
grape seeds.
… AND MODERN INSIGHTS INTO OPC HEALTH BENEFITS
•DIETARY SUPPLEMENTS (Mostly in the area of CVDs and stimulated by the
“French Paradox”* induced cascade of literature)
PREVENTION/RISK REDUCTION
•PHARMACEUTICAL PRODUCTS (Mostly concerned with vascular protection)
THERAPY
*S. Renaud and M. de Lorgeril, Lancet 339, 1523 (1992);
M. de Lorgeril et al., Cardiovas. Res. 54, 503 (2002).
THE RELEVANCE OF OPC AND RESVERATROL IN THE EPIDEMIOLOGICAL SCENARIO From “French Paradox” to “red wine paradox”?
Resveratrol in wine: 5 mg/L
One glass of 250 mL/day = 1.25 mg = 18 µg/kg
Oligomeric procyanidins in wine: 600 mg/L
One glass of 250 mL/day = 150 mg = 2.14 mg/kg
for a man of 70 kg b.w.
A. Giacosa et al., Eur. J. Cancer Prev. 22, 90 (2013)
OPC: AN unicum AMONG POLYPHENOLS
• HIGH TROPISM FOR THE VASCULAR TISSUE
n 0 - 5
O
OH
OH
HO
OH
3
4
R
O
OH
OH
HO
OH
3
4
R
O
OH
OH
HO
OH
3
R
8
8
OLIGOMERIC PROCYANIDINS
• CAPACITY TO MODULATE ENDOTHELIAL
FUNCTIONAL RESPONSE
HIGH TROPISM FOR THE VASCULAR TISSUE
TISSUE DISTRIBUTION OF RADIOACTIVITY AFTER ORAL ADMINISTRATION OF 14C-LABELLED OPC IN RODENTS
Total blood
Muscle
Heart
Plasma
Lung
Adrenals
Spleen
Xiphoid cartilage
Skin
Kidney ( cortex )
Trachea
Liver
Duodenum
Aorta
6.310
6.885
7.459
8.677
10.424
11.370
12.822
17.504
17.864
22.534
24.427
34.056
42.579
49.205
±
±
±
±
±
±
±
±
±
±
±
±
±
±
1.671
1.301
1.588
2.203
2.220
3.217
3.141
4.113
4.216
6.399
5.740
9.024
10.346
11.513
Tissue dpm / g % radioactivity
( vs. blood )
1
1.09
1.18
1.37
1.65
1.80
2.03
2.77
2.83
3.57
3.87
5.40
6.75
7.80
J. Laparra et al.: Plantes médicinales et phytothérapie 11, 133 (1977)
OPC: DEMONSTRATED BASIC MECHANISMS REGULATING FUNCTIONAL ASPECTS IN MAINTAINING CARDIOVASCULAR HEALTH
• ACTIVATION AND UP-REGULATION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE
• STIMULATION OF AN ENDOTHELIUM DEPENDENT RELAXATION OF BLOOD VESSELS
- M.B. Cishek et al., Clin. Sci. 97, 507 (1997)
- I. Edirisinghe et al., Clin. Sci. 114, 331 (2008)
- M. Ndiaye et al., Br. J. Pharmacol. 142, 1131 (2004); The FASEB Journal 19, 455 (2005)
O
OH
OH
HO
OH
3
4
R
O
OH
OH
HO
OH
3
4
R
O
OH
OH
HO
OH
3
R
8
8
OLIGOMERIC PROCYANIDINS
- M. Ndiaye et al., Br. J. Pharmacol. 142, 1131 (2004); The FASEB Journal 19, 455 (2005)
Schematic diagram showing the OPC-induced endothelium-dependent NO-mediated relaxation in the isolated porcine coronary artery
OPC: THE INDENA EXPERIENCE
IN ORDER TO CAPITALIZE
THIS IMPORTANT BACKGROUND WE STARTED YEARS AGO
WITH THE CHALLENGING TARGET TO
STANDARDIZED GRAPE SEEDS EXTRACTS
HIGHLY STANDARDIZED GRAPE SEEDS EXTRACTS: GENERAL MANUFACTURING PROCESS
ANALYSIS
OF THE
FINAL PRODUCT
ANALYSIS OF THE
FINAL PRODUCT
EXTRACTION PURIFICATION BY
SELECTIVE COUNTEREXTRACTION
CONCENTRATION
TO
AQUEOUS EXTRACT
FILTRATION
ATOMIZATION
MIXING / SIEVING
CONCENTRATION
TO
SOFT EXTRACT
DISSOLVE
IN WATER
GRAPE SEEDS
1) Extract GRAPE SEEDS, at room temperature, ....until exhaustion.
2) Concentrate the percolates in vacuum, under ....mild and controlled temperature conditions, ....until elimination of the extraction solvent.
3) Filter the aqueous concentrate obtained, to ....eliminate any precipitated material.
4) Purify the filtered solution by selective ....counterextraction.
5) Concentrate the purified product in vacuum, ....under mild and controlled temperature ....conditions, to yield a soft extract.
6) Dissolve the soft extract in water.
7) Atomize the aqueous solution obtained.
8) Mix the dried product and sieve it.
9) Send the final product for quality control analysis (HPLC-UV, HPLC-GPC) and packaging.
GRAPE SEEDS EXTRACTS PRODUCED BY INDENA
All these products are standardized dry extracts from grape seeds, and contain the purified fraction of characteristic grapes polyphenols. The products are manufactured in the same authorized industrial plant, by means of food grade solvents according to EU and US specifications. ENOVITA complies also with Japanese specifications, being produced with water and ethanol only.
ENOVITA
LEUCOSELECT
GRAPE SEED MONOMERS
OPC: THE INDENA EXPERIENCE
HIGHLY STANDARDIZED GRAPE SEEDS EXTRACTS
ALLOW
PRE-CLINICAL
AND
CONTROLLED CLINICAL INVESTIGATIONS
Comparative analytical data (according to USP)
WATER
(%)
MONOMERS
(%)
OPC
(%)
INSOLUBLE
RESIDUAL
(%)
ENOVITA 5.3 8.6 91.4 0.03 99
GRAPE SEED MONOMERS 3.3 21.4 82.3 0.50 103
OPC
MONOMERS
(%)
+
PRODUCT
GRAPE SEEDS EXTRACTS PRODUCED BY INDENA
OPC rich grape seeds extract is made exclusively with grape seeds from white wine production. Using only water as extraction solvent, ENOVITA is a food grade grape seed extract whose development has capitalized on Indena's 40 years experience in grape seed extract production. ENOVITA is produced according to Indena 30 Quality system and under HACCP conditions in a GMPs and ISO 14001 certified facility, ensuring full traceability from grape harvest to the finished product. Furthermore, ENOVITA is Halal and Kosher certified and its environmental friendly production process is designed to minimize the production of waste.
Stratification of total CV risk in categories of low, moderate, high and very high risk according to SBP and DBP and prevalence of RFs, asymptomatic OD, diabetes, CKD stage or symptomatic CVD.
NUMBER OF SUBJECTS: 119 TREATMENT GROUPS:
- Control (28 males + 19 females = 47) - ENOVITA 150 mg/day (17 males + 18 females = 35) - ENOVITA 300 mg/day (23 males + 14 females = 37) PERIOD OF TREATMENT: 16 weeks EVALUATION OF THE EFFECTS:
Blood pressure and blood flow at microcirculation level (foot skin) by Laser Doppler flowmetry; heart rate and plasma free radicals.
Mild hypertension: pre hypertension (120-139 / 80-89 mmHg) and Stage 1 hypertension (140-159 / 90-99 mmHg). All patients were undergoing Best Standard Management: weight control, exclusion of NaCl, caffeine, soft drinks and drinks containing caffeine; physical exercise 20 minutes/2 times/day.
ENOVITA
Registry study in mild hypertensive subjects (undergoing Best Standard Management)
Evidence-Based Complementary and Alternative Medicine, Volume 2013, Article ID 313142, http://dx.doi.org/10.1155/2013/313142
ENOVITA: effects on blood pressure and peripheral blood flow in mild hypertensive subjects
Evidence-Based Complementary and Alternative Medicine, Volume 2013, Article ID 313142, http://dx.doi.org/10.1155/2013/313142
ENOVITA: effects on heart rate and plasma free radicals in mild hypertensive subjects
Evidence-Based Complementary and Alternative Medicine, Volume 2013, Article ID 313142, http://dx.doi.org/10.1155/2013/313142
CONCLUSIONS
In healthy subjects bordering hypertension, the combination of the Best Standard
Management with ENOVITA (150-300 mg/day for at least 4 weeks) can
positively modulate blood pressure and blood flow at the level of
microcirculation.
This effect is paralleled by a significant reduction in heart rate.
A relevant reduction of plasma free radicals has also been observed.
ENOVITA has been well tolerated with a global positive compliance.
ENOVITA: registry study in mild hypertensive subjects (undergoing Best Standard Management)
ENOVITA OVERALL CONCLUSIONS
• OPC are the most characterizing polyphenols of Vitis vinifera L.
• Standardization of grape seeds extracts containing OPC is still a challenging task
• Highly standardized grape seeds extracts containing OPC are:
– clinically documented as venotropic agents – strongly effective in modulating endothelial functionality – promising co-adjuvant agents in reducing intermediate – risk factors (i.e. ENOVITA on blood pressure) in CVDs
Twitter YouTube Flickr LinkedIn
Indena.com